Aladdin Healthcare Technologies SE
ALDNF · OTC
12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | -100% | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | -$0 | -$0 | $0 | $0 |
| % Margin | – | – | 100% | – |
| R&D Expenses | $0 | $1 | $0 | $0 |
| G&A Expenses | $0 | $1 | $1 | $0 |
| SG&A Expenses | $0 | $1 | $1 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $1 | $2 | $2 | $0 |
| Operating Income | -$1 | -$2 | -$4 | -$0 |
| % Margin | – | – | -2,198.6% | – |
| Other Income/Exp. Net | -$0 | -$1 | -$1 | $0 |
| Pre-Tax Income | -$1 | -$3 | -$4 | -$0 |
| Tax Expense | -$0 | -$0 | $2 | $0 |
| Net Income | -$1 | -$3 | -$4 | -$0 |
| % Margin | – | – | -2,219.6% | – |
| EPS | -0.11 | -0.19 | -0.35 | -0.002 |
| % Growth | 42.1% | 45.7% | -15,809.1% | – |
| EPS Diluted | -0.11 | -0.19 | -0.35 | -0.002 |
| Weighted Avg Shares Out | 11 | 16 | 11 | 12 |
| Weighted Avg Shares Out Dil | 11 | 16 | 11 | 12 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $2 | $0 | $0 |
| EBITDA | -$1 | -$0 | -$2 | -$0 |
| % Margin | – | – | -979% | – |